Areny-Balagueró, A.; Mekseriwattana, W.; CamprubÃ-Rimblas, M.; Stephany, A.; Roldan, A.; Solé-Porta, A.; Artigas, A.; Closa, D.; Roig, A.
Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge. Pharmaceutics 2022, 14, 1447.
https://doi.org/10.3390/pharmaceutics14071447
AMA Style
Areny-Balagueró A, Mekseriwattana W, CamprubÃ-Rimblas M, Stephany A, Roldan A, Solé-Porta A, Artigas A, Closa D, Roig A.
Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge. Pharmaceutics. 2022; 14(7):1447.
https://doi.org/10.3390/pharmaceutics14071447
Chicago/Turabian Style
Areny-Balagueró, Aina, Wid Mekseriwattana, Marta CamprubÃ-Rimblas, Andrea Stephany, Ariana Roldan, Anna Solé-Porta, Antonio Artigas, Daniel Closa, and Anna Roig.
2022. "Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge" Pharmaceutics 14, no. 7: 1447.
https://doi.org/10.3390/pharmaceutics14071447
APA Style
Areny-Balagueró, A., Mekseriwattana, W., CamprubÃ-Rimblas, M., Stephany, A., Roldan, A., Solé-Porta, A., Artigas, A., Closa, D., & Roig, A.
(2022). Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge. Pharmaceutics, 14(7), 1447.
https://doi.org/10.3390/pharmaceutics14071447
